FOLLOW US

Endocrine Research Updates

For Medical Professionals

Patients report that being told by doctors that they have a 'good cancer' invali
Patients report that being told they have a good cancer invalidates their fears and creates mixed and confusing emotions
Rate of hypothyroidism are double in those working the longest hours
Rates of hypothyroidism are double in those working the longest hours
A new way to lower medical costs for patients with diabetes
A new way to lower medical costs for patients with diabetes
The new drug is a game changer for patients with TED
The new drug is a game changer for patients with TED
The first drug specifically for the treatment of thyroid eye disease has been approved by the FDA.
More than 80 percent of patients had remission within 5 years of surgery
More than 80 percent of patients had remission within 5 years of surgery
For patients with diabetes, dental hygiene is even more important
For patients with diabetes, it is even more important to remember the relationship between oral health and general health

For patients with diabetes, it is even more important to remember the relationship between oral health and general health

Telemedicine & COVID-19: What To Know Now
With relaxed restrictions on telemedicine, thousands of doctors are jumping on board. What to know, where to get help, and how to reassure your patients.

With relaxed restrictions on telemedicine, thousands of doctors are jumping on board. What to know, where to get help, and how to reassure your patients.

Timing is the critical factor in whether steroids help or harm COVID-19 patients
Timing is the critical factor in whether steroids help or harm COVID-19 patients with endocrine conditions
New agents improve glucose control in type 1 diabetes, and CV outcomes in T2D
In reviewing key trial findings, the Food and Drug Administration has granted approval to drugs that promise better glucose control or lipid-lowering efficacy.
Lorcaserin has been recalled for concerns about elevated cancer risk.
Oral testosterone for adult men with androgen deficiency available, cancer concerns over lorcaserin, and push to bring more biosimilars to market.
The effects of antibiotic use on body weight are evaluated based on use during pregnancy and into the first 4 years of life with findings of a modest, dose-dependent association.
Drug increased brown fat which revs up metabolic effects..
Introducing a beta3-AR agonist, mirabegron, shows increases in energy expenditure, insulin sensitivity, and improved levels of circulating fats, according to ongoing research at the NIH.
Hyperthyroidism appears associated with development of dementia.
Graves’ disease and toxic nodular goiter increase the odds that these patients will develop dementia, including Alzheimer’s disease and vascular dementia, a relationship perhaps driven by prolonged low TSH.
People should get tested for Lp(a) levels at least once to rule out CVD risk.
A strong case is made for testing lipoprotein(a) levels at least once early in life to ascertain future risk of coronary artery disease.
With all the upsides, how often are you actively implementing a management care plan for the many at-risk patients that present in your practice?
One pill delivering 3 forms of glucose lowering power improve outcome.
As the challenge of attaining better glucose control grows, introducing the first three-in-one therapy may lead to better outcomes with greater ease and lower cost.
Insulin clearance has been introduced as a factor in the onset of diabetes
A fresh look at factors affecting progression of type 2 diabetes led Cedars Sinai researchers to consider the possibility that insulin clearance in the liver may play a key role.
When adrenal mass is accidently seen on imaging, assessment may benefit patient.
The presence of adrenal incidentalomas appears increasingly more common and detecting these benign tumors reflects an increased rate of type 2 diabetes but any direct clinical meaning remains elusive, according to recent study findings.
close X
SHOW MAIN MENU
SHOW SUB MENU